New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 26, 2014
13:25 EDTJAZZ, JAZZ, JAZZ, SLXP, SLXP, SLXPLeerink's specialty pharma analyst holds analyst/industry conference call
Specialty Pharmaceuticals Analyst Gerberry discusses the prospects for Jazz Pharmaceuticals/Sigma Tau's Defibrotide approval in the U.S., and provides an assessment of challneges facing two key specialty pharma controversies: Defibrotide and Relistor on an Analyst/Industry conference call to be held on February 27 at 2 pm.
News For JAZZ;SLXP From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 24, 2014
08:15 EDTJAZZJazz Pharmaceuticals price target raised to $201 from $163 at Canaccord
Subscribe for More Information
October 23, 2014
18:18 EDTSLXPGlenview Capital acquires stake in Actavis, Bloomberg reports
Subscribe for More Information
October 21, 2014
07:07 EDTSLXPSalix to present results of TARGET 3 study with Rifaximin 550mg for IBS
Subscribe for More Information
October 17, 2014
07:53 EDTJAZZJazz Pharmaceuticals shares 'signifincantly undervalued,' says FBR Capital
Subscribe for More Information
October 16, 2014
15:10 EDTSLXPAmerican College of Gastroenterology to hold annual meeting
ACG Annual Scientific Meeting 2014 to be held in Philadlephia, PA on October 17-22.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use